ArticleThe International journal on drug policy2019

Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.

Joshua A Barocas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.